Przemysław Langiewicz
Impact in
-
- Renal cell carcinoma treatment
- Ferroptosis and cancer prognosis
-
- Cancer Genomics and Diagnostics
Papers in
-
- Renal cell carcinoma treatment 4
-
- Renal Transplantation Outcomes and Treatments 1
- Co-authors
- B. Yа. Alekseev (2 shared papers)Michael B. Atkins (2 shared papers)Frede N. Donskov (1 shared paper)Georg Arnold Bjarnason (1 shared paper)Paweł Wiechno (1 shared paper)Rustem Airatovich Gafanov (1 shared paper)Frédéric Pouliot (1 shared paper)Marek Ziobro (1 shared paper)
- Journals
- European Urology Oncology (1 paper)Journal of Cancer Research and Clinical Oncology (1 paper)Kidney & Blood Pressure Research (1 paper)Journal of Clinical Oncology (1 paper)PubMed (1 paper)
- Partner nations
- PolandUnited StatesRussia
In The Last Decade
Przemysław Langiewicz
5 papers receiving 325 citations
Przemysław Langiewicz's Hit Papers
Peers
Comparison fields: 5 of 37
- Pulmonary and Respiratory Medicine 234
- Cancer Research 67
- Oncology 103
- Molecular Biology 101
- Surgery 31
Countries citing papers authored by Przemysław Langiewicz
This map shows the geographic impact of Przemysław Langiewicz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Przemysław Langiewicz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Przemysław Langiewicz more than expected).
Fields of papers citing papers by Przemysław Langiewicz
This network shows the impact of papers produced by Przemysław Langiewicz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Przemysław Langiewicz. The network helps show where Przemysław Langiewicz may publish in the future.
Co-authors
The 25 scholars most cited alongside Przemysław Langiewicz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Open-Label, Single-Arm, Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Non–Clear Cell Renal Cell Carcinoma Hit paper breakdown → | 2021 | 224 |
| 2 | 2011 | 39 | |
| 3 | 2009 | 29 | |
| 4 | 2021 | 29 | |
| 5 | Allogeneic non-myeloablative hematopoietic stem cell transplantation for treatment of metastatic renal cell carcinoma -- single center experience. | 2005 | 7 |
About Przemysław Langiewicz
Przemysław Langiewicz is a scholar working on Pulmonary and Respiratory Medicine, Transplantation, Hematology, Oncology and Insect Science, having authored 5 papers that have together received 328 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (4 papers), Hematopoietic Stem Cell Transplantation (1 paper), Polyomavirus and related diseases (1 paper) and Renal Transplantation Outcomes and Treatments (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (234 citations), Cancer Research (67 citations), Oncology (103 citations), Molecular Biology (101 citations) and Surgery (31 citations). Przemysław Langiewicz has collaborated with scholars based in Poland, United States and Russia. Frequent co-authors include B. Yа. Alekseev, Michael B. Atkins, Frede N. Donskov, Georg Arnold Bjarnason, Paweł Wiechno, Rustem Airatovich Gafanov, Frédéric Pouliot, Marek Ziobro, Sang Joon Shin and Piotr Tomczak. Their work appears in journals such as European Urology Oncology, Journal of Cancer Research and Clinical Oncology, Kidney & Blood Pressure Research, Journal of Clinical Oncology and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.